CLINICAL RESEARCH
The Extent of Perfusion–F18-Fluorodeoxyglucose Positron Emission Tomography Mismatch Determines Mortality in Medically Treated Patients With Chronic Ischemic Left Ventricular Dysfunction
Alessandro Desideri, MD, FACC*,*,
Lauro Cortigiani, MD*,
Alejandra Ines Christen, MD*,
Sebastian Coscarelli, MD*,
Dario Gregori, PhD ,
Pierluigi Zanco, MD ,
Roman Komorovsky, MD* and
Jeroen J. Bax, MD
* Cardiovascular Research Foundation, "S. Giacomo" Hospital, Castelfranco Veneto, Italy
Department of Public Health and Microbiology, University of Torino, Torino, Italy
PET Center, Nuclear Medicine Department, "S. Giacomo" Hospital, Castelfranco Veneto, Italy
Department of Cardiology, Leiden University Medical Center, Leiden, the Netherlands
Manuscript received February 28, 2005;
revised manuscript received June 7, 2005,
accepted June 13, 2005.
* Reprint requests and correspondence: Dr. Alessandro Desideri, Cardiovascular Research Foundation, S. Giacomo Hospital, 31033 Castelfranco Veneto (TV), Italy
(Email: aldesi{at}tin.it).
OBJECTIVES: The purpose of this study was to assess the determinants of mortality in a large group of patients with ischemic cardiomyopathy who are treated medically and the impact of the extent of viable tissue on prognosis.
BACKGROUND: Whether the presence of viability drives mortality in patients with ischemic cardiomyopathy who are treated medically and whether the extent of viability is important are issues that are currently unclear.
METHODS: Two hundred sixty-one patients with ischemic cardiomyopathy underwent positron emission tomography (PET) for assessment of viability. Prospective follow-up was obtained.
RESULTS: Ninety-four patients were revascularized and 167 were not. The cardiac death rate was significantly less in the revascularized patients as compared with medically treated patients (13% vs. 24%, p < 0.05). In the revascularized patients, there was a trend toward better survival in patients with viable myocardium as compared with nonviable myocardium (3.5-year survival, 85% and 75% respectively, p = NS). In the medically treated group, age (hazard ratio [HR] 2.1, 95% confidence interval [CI] 1.2 to 3.7), presence of left bundle branch block (HR 3.4, 95% CI 1.6 to 7.2) and extent of perfusion-metabolism mismatch on PET (HR 1.36, 95% CI 1.1 to 1.6) predicted cardiac death during a median follow-up period of 2.1 years. The risk of cardiac death was not significantly increased when the extent of mismatch was  20% (HR 0.97, 95% CI 0.46 to 2.05) but was significantly increased when the extent of mismatch was >20% (HR 3.21, 95% CI 1.38 to 7.49).
CONCLUSIONS: Medically treated patients with ischemic cardiomyopathy and large areas of viable myocardium on PET are at high risk for cardiac death.
|
Abbreviations and Acronyms
| | CABG = coronary artery bypass graft | | CAD = coronary artery disease | | EF = ejection fraction | | FDG = F18-fluorodeoxyglucose | | LBBB = left bundle branch block | | LV = left ventricle/ventricular | | MI = myocardial infarction | | PET = positron emission tomography |
|
This article has been cited by other articles:
|
|
|
|
 
X. Zhang, X.-j. Liu, S. Hu, T. H. Schindler, Y. Tian, Z.-x. He, R. Gao, Q. Wu, H. Wei, J. W. Sayre, et al.
Long-Term Survival of Patients with Viable and Nonviable Aneurysms Assessed by 99mTc-MIBI SPECT and 18F-FDG PET: A Comparative Study of Medical and Surgical Treatment
J. Nucl. Med.,
August 1, 2008;
49(8):
1288 - 1298.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. G. Camici, S. K. Prasad, and O. E. Rimoldi
Stunning, Hibernation, and Assessment of Myocardial Viability
Circulation,
January 1, 2008;
117(1):
103 - 114.
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. S.B. Beanlands, G. Nichol, E. Huszti, D. Humen, N. Racine, M. Freeman, K. Y. Gulenchyn, L. Garrard, R. deKemp, A. Guo, et al.
F-18-Fluorodeoxyglucose Positron Emission Tomography Imaging-Assisted Management of Patients With Severe Left Ventricular Dysfunction and Suspected Coronary Disease: A Randomized, Controlled Trial (PARR-2)
J. Am. Coll. Cardiol.,
November 13, 2007;
50(20):
2002 - 2012.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. J. Gibbons, P. A. Araoz, and E. E. Williamson
The Year in Cardiac Imaging
J. Am. Coll. Cardiol.,
December 5, 2006;
48(11):
2324 - 2339.
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. J. Gibbons, P. Chareonthaitawee, and K. R. Bailey
Revascularization in Systolic Heart Failure: A Difficult Decision
Circulation,
January 17, 2006;
113(2):
180 - 182.
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. N. DeMaria, O. Ben-Yehuda, D. Berman, G. K. Feld, G. S. Ginsburg, B. H. Greenberg, W. Y.W. Lew, D. Sahn, and S. Tsimikas
Highlights of the Year in JACC 2005
J. Am. Coll. Cardiol.,
January 3, 2006;
47(1):
184 - 202.
[Full Text]
[PDF]
|
|
|
|
